BloodPressureHeartMeds.Net

Enzyme Research journal publishes new peer-reviewed article involving Protandim

April 07, 2017

The authors conclude that oxidative stress forms a mechanistic linkage between cell proliferation, inflammation, and apoptosis, suggesting that potent multimodal antioxidant inducers may potentially be utilized with conventional chemotherapeutics.  They note that efforts are currently underway to discover and develop compounds that effectively induce manganese superoxide dismutase (MnSOD) in hopes of incorporating antioxidant-based therapies into current clinical practice. They suggest that the development of various MnSOD inducers to be used during the early-onset of tumorigenesis may represent a plausible approach to suppress underlying mechanisms involved in carcinogenesis.

"This work was conceived, funded and created by investigators at the Louisiana State University Health Sciences Center at Shreveport, completely independent of LifeVantage," stated Douglas Robinson, LifeVantage CEO.  "LifeVantage greatly appreciates the continuing academic interest in Protandim? shown by researchers such as Dr. Zhao and his colleagues.  This scholarly contribution underscores the current value and future potential with which Protandim? is being viewed by the biomedical research community, particularly with regard to health conditions associated with oxidative stress."  

SOURCE LifeVantage Corporation